Artin Bioscience Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-13. The offering totals $483K, of which $483K was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| David Doyle | Director | Arlington Hts., IL |
| Erik Eglite | Director | Lake Forest, IL |
| Charles Magolske | Director | Denver, CO |
| Norbert Voelkel | Director | Denver, CO |
| David Doyle | Executive Officer | Arlington Hts., IL |
| Erik Eglite | Executive Officer | Lake Forest, IL |
| Charles Magolske | Executive Officer | Denver, CO |